Craig Hallum initiated coverage on Adaptive Biotechnologies with a new price target

6/18/25 8:08:30 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Craig Hallum initiated coverage of Adaptive Biotechnologies with a rating of Buy and set a new price target of $15.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ADPT

Date	Price Target	Rating	Analyst
6/18/2025	$15.00	Buy	Craig Hallum
3/21/2025	$9.00	Neutral → Buy	Goldman
7/5/2023	$15.00	Overweight	JP Morgan
1/5/2023	$15.00	Sector Outperform	Scotiabank
12/21/2022	$7.50 → $14.00	Neutral → Overweight	Piper Sandler
8/25/2022	$8.00	Underperform	Credit Suisse
6/3/2022	$7.50	Neutral	Piper Sandler
2/16/2022	$40.00 → $32.00	Buy	BofA Securities